X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
humans (12) 12
female (7) 7
male (7) 7
middle aged (7) 7
pharmacology & pharmacy (7) 7
aged (6) 6
adult (5) 5
expression (5) 5
pharmacokinetics (5) 5
drug dosages (4) 4
immunoconjugates - pharmacokinetics (4) 4
research (4) 4
animals (3) 3
antibodies, monoclonal - pharmacokinetics (3) 3
biomarkers (3) 3
immunoconjugates - therapeutic use (3) 3
models, biological (3) 3
oligopeptides - pharmacokinetics (3) 3
pharmacology (3) 3
pharmacology/toxicology (3) 3
safety (3) 3
studies (3) 3
treatment outcome (3) 3
young adult (3) 3
abridged index medicus (2) 2
adolescent (2) 2
aged, 80 and over (2) 2
analysis (2) 2
antibodies (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibody-drug conjugate (2) 2
antibody-drug conjugates (2) 2
antineoplastic agents - pharmacokinetics (2) 2
antineoplastic agents - therapeutic use (2) 2
asthma (2) 2
binding (2) 2
biochemistry, general (2) 2
biomedicine (2) 2
biopharmaceutics (2) 2
body weight (2) 2
care and treatment (2) 2
cholesterol, hdl - blood (2) 2
chronic lymphocytic-leukemia (2) 2
computer simulation (2) 2
conjugates (2) 2
darunavir (2) 2
drug interactions (2) 2
drug resistance, neoplasm (2) 2
half-life (2) 2
health aspects (2) 2
healthy-volunteers (2) 2
hematology (2) 2
hiv (2) 2
hiv protease inhibitors - pharmacology (2) 2
immunoconjugates - pharmacology (2) 2
metastatic breast-cancer (2) 2
monoclonal antibodies (2) 2
monoclonal-antibody (2) 2
oligopeptides - chemistry (2) 2
omalizumab (2) 2
oncology (2) 2
pharmaceuticals (2) 2
pharmacodynamics (2) 2
pharmacy (2) 2
phase-i (2) 2
potent (2) 2
retreatment (2) 2
risk factors (2) 2
rosuvastatin (2) 2
triglycerides - blood (2) 2
vc-mmae adcs (2) 2
vedotin (2) 2
viral antibodies (2) 2
125i-radiolabeling (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
acquired-immunodeficiency-syndrome (1) 1
acute myeloid-leukemia (1) 1
administration, inhalation (1) 1
adrenal cortex hormones - administration & dosage (1) 1
adults (1) 1
allergens (1) 1
allergic asthma (1) 1
allergies (1) 1
allergy (1) 1
allergy and immunology (1) 1
alternative rna (1) 1
analytical chemistry (1) 1
anti-asthmatic agents - administration & dosage (1) 1
anti-asthmatic agents - adverse effects (1) 1
anti-cd22 (1) 1
anti-hiv agents - adverse effects (1) 1
anti-hiv agents - therapeutic use (1) 1
antibodies, anti-idiotypic - administration & dosage (1) 1
antibodies, monoclonal - chemistry (1) 1
antibodies, monoclonal - immunology (1) 1
antibodies, monoclonal - pharmacology (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antibody–drug conjugates (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 138, Issue 6, pp. 1730 - 1732
  To the Editor: Chronic spontaneous urticaria (CSU) presents as recurrent itchy wheals, angioedema, or both for at least 6 weeks without a specific trigger.1... 
Allergy and Immunology | OMALIZUMAB | ALLERGY | IMMUNOLOGY | Urticaria | Adults | Studies | Pathogenesis | Allergies | Asthma
Journal Article
Respiratory Research, ISSN 1465-9921, 03/2016, Volume 17, Issue 1, p. 29
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 6/2012, Volume 52, Issue 6, pp. 922 - 931
HIV-1 protease inhibitors often cause dyslipidemia, necessitating the use of lipid-lowering agents such as rosuvastatin. However, when given concomitantly,... 
protease inhibitors | pharmacokinetics | darunavir | drug interactions | rosuvastatin | statins | DRUG | HEPATOCYTES | RECEIVING ANTIRETROVIRAL THERAPY | TRANSPLANT RECIPIENTS | EFFLUX TRANSPORTERS | PHARMACOLOGY & PHARMACY | LOPINAVIR/RITONAVIR | PRAVASTATIN | HEALTHY-VOLUNTEERS | EXPRESSION | Fluorobenzenes - pharmacokinetics | Darunavir | Pyrimidines - blood | Cholesterol - blood | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - blood | Middle Aged | Half-Life | Male | Fluorobenzenes - pharmacology | HIV Protease Inhibitors - pharmacology | Young Adult | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Sulfonamides - blood | Drug Interactions | Ritonavir - adverse effects | Time Factors | HIV Protease Inhibitors - pharmacokinetics | Adult | Female | Ritonavir - pharmacology | Fluorobenzenes - blood | HIV Protease Inhibitors - adverse effects | HIV Protease Inhibitors - blood | Ritonavir - blood | Rosuvastatin Calcium | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Sulfonamides - pharmacokinetics | Cross-Over Studies | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Ritonavir - pharmacokinetics | Pyrimidines - adverse effects | Triglycerides - blood | Cholesterol, HDL - blood | Pyrimidines - pharmacokinetics | Sulfonamides - adverse effects | Fluorobenzenes - adverse effects | Metabolic Clearance Rate - drug effects | Drug Combinations | Care and treatment | Rosuvastatin | HIV (Viruses) | Drug therapy | Pharmacokinetics | Health aspects
Journal Article
CPT: Pharmacometrics & Systems Pharmacology, ISSN 2163-8306, 08/2019, Volume 8, Issue 8, pp. 606 - 615
Peripheral neuropathy (PN) is a common long‐term debilitating toxicity of antimicrotubule agents. PN was the most frequent adverse event resulting in dose... 
Studies | Antigens | Cell division | Trends | Peripheral neuropathy | Patients | Cancer therapies | Drug dosages | Risk factors | Research
Journal Article
Expert review of clinical pharmacology, 12/2016, Volume 9, Issue 12, p. 1557
Suboptimal treatment for monoclonal antibodies (mAbs) directed against endogenous circulating soluble targets and the shed extracellular domains (ECD) of the... 
Animals | Antibodies, Monoclonal - administration & dosage | Immunomodulation | Antibodies, Monoclonal - pharmacology | Humans | Antibodies, Monoclonal - pharmacokinetics | Antigens - immunology | Ligands | Antibodies, Monoclonal - immunology
Journal Article
Journal of Pharmacokinetics and Pharmacodynamics, ISSN 1567-567X, 12/2017, Volume 44, Issue 6, pp. 537 - 548
Journal Article
mAbs, ISSN 1942-0862, 01/2020, Volume 12, Issue 1, pp. 1699768 - 1699768
vc-MMAE antibody-drug conjugates (ADCs) consist of a monoclonal antibody (mAb) covalently bound with a potent anti-mitotic toxin (MMAE) through a... 
pharmacokinetics | first-in-human studies | exposure-response analysis | vc-MMAE ADCs | Antibody-drug conjugate | Index Medicus
Journal Article
Clinical and Translational Science, ISSN 1752-8054, 09/2019, Volume 12, Issue 5, pp. 534 - 544
Prediction of human pharmacokinetics (PK) based on preclinical information for antibody–drug conjugates (ADCs) provide important insight into first‐in‐human... 
MEDICINE, RESEARCH & EXPERIMENTAL | CLEARANCE | OZOGAMICIN | SAFETY | VEDOTIN | LYMPHOMA | LEUKEMIA | PHASE-I | CANCER | ANTI-CD22 | Viral antibodies | Antibodies | Analysis | Biopharmaceutics | Analytical chemistry | Conjugates | Immunoglobulins | Leukemia | Body weight | Cytotoxicity | Pharmacology | FDA approval | Studies | Epidermal growth factor | Predictions | Scaling | Lymphomas | Pharmacokinetics | Drug dosages | Methods | Pharmaceuticals | Index Medicus | Research
Journal Article
Expert Review of Clinical Pharmacology, ISSN 1751-2433, 12/2016, Volume 9, Issue 12, pp. 1557 - 1569
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1614 - 1614
Abstract Introduction FL is characterized by the translocation t(14;18), resulting in constitutive overexpression of the key anti-apoptotic protein BCL2. Ven,... 
Journal Article
Blood Cancer Journal, ISSN 2044-5385, 02/2019, Volume 9, Issue 2, pp. 17 - 12
Journal Article
Journal Article
Journal Article
Journal Article